Biosynthetic retrovectoring systems for gene therapy

Journal of Molecular Medicine

Volumn 75, Issue 4, 1997, Pages 249-258

  Hodgson, Clague P ^a,b,c   Xu, Guoping ^c   Solaiman, Fauzia ^c   Zink, Mary Ann ^c,d,e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MARYVILLE COLLEGE   (United States)

^e CREIGHTON UNIVERSITY   (United States)

Author keywords

gene therapy; retrotransposon(s); retrovirus; vector(s); VL30

Indexed keywords

LIPOSOME; VIRUS VECTOR;

GENE THERAPY; GENETIC TRANSFECTION; MOUSE; NONHUMAN; RETROPOSON; RETROVIRUS; REVIEW;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIPOSOMES; RETROELEMENTS; RETROVIRIDAE;

EID: 0030965092     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050110     Document Type: Review

References (50)

1. Zarling D, Sena E (1993) In vivo homologous sequence targeting in eukaryotic cells. World Intellectual Property Organization (WIPO) patent WO 93/22443
2. Wei C, Gibson M, Spear P, Scolnick E (1980) Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type I. J Virol 39:935-944
3. Shimotohno K, Temin H (1981) Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell 26:67-77
4. Hughes S, Greenhouse J, Petropoulos, C, Sutrave P (1987) Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol 61:3004-3012
5. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage F, Verma I, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral sector. Science 272:263-267
6. Donahue R, Kessler S, Bodine D (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125-1135
7. Hoeben R, Migchielsen A, van der Jagt R, van Ormondt H, van der EB A (1991) Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dewpendent on its chromosomal position. J Virol 65:904-912
8. Chalita P, Kohn D (1994) Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 91:2567-2571
9. Hodgson C (1996) Retroviral helper cells. In Hodgson CP (ed) Retro-vectors for human gene therapy. Chapman & Hall, New York; Springer, Berlin Heidelberg New York, pp 53-72
10. Otto E, Jones-Trower A, Vanin E, Stambaugh K, Mueller S, Anderson W, McGarrity O (1994) Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther 5:567-575
11. Purcell D, Broscius C, Vanin E, Buckler C, Nienhuis A, Martin M (1996) An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J Virol 70:887-897
12. Dougherty J, Wisniewski R, Yang S (1991) New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J Virol 63:3209-3212
13. Martinez, I, Dornberg R (1996) Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes. Hum Gene Ther 7:705-712
14. Cook R, Cook S, Hodgson C (1991) Retrotransposon gene engineering Biotechnology 9:748-751
15. Sherwin S, Rapp U, Benveniste R (1978) Rescue of endogenous 30S retroviral sequences from mouse cells by baboon type C virus. J Virol 26:257-264
16. Hatzoglou M, Hodgson C, Mularo F, Hanson R (1990) Transfer and expression of mouse VL30 retroelements in rat cells during infection with recombinant MoMLV viruses. Hum Gene Ther 1:385-397
17. Chakraborty A, Zink M, Hodgson C (1994) Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy. Cancer Gene Ther 1:113-118
18. Cook R, Cook S, Hodgson, C (1991) Retrotransposon gene engineering. Biotechnology 9:748-751
19. Hodgson C, Zink M, Xu G (1996) Structure and function of mouse VL30 sequences. In: Hodgson CP (ed) Retro-vectors for human gene therapy. Chapman & Hall, New York; Springer, Berlin, Heidelberg.
20. Hodgson C, Chakraborly A, Zink M, Xu G (1996) Construction, transmission and expression of synthetic VL30 vectors. In: Hodgson CP (ed) Retro-vectors for human gene therapy, Chapman & Hall, New York; Springer, Berlin, Heidelberg
21. Chakraborty A, Zink M, Hodgson C (1993) Synthetic retrotransposon vectors for gene therapy FASEB J 7:971-977
22. Berlioz, C, Darlix J (1995) An internal ribosome entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J Virol 69:2214-2222
23. Berlioz C, Torrent C, Darlix J (1995) An internal ribosome entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors. J Virol 69:6400-6407
24. Eaton L, Norton J (1990) Independent regulation of mouse VL30 retrotransposon expression in response to serum and oncogenic cell transformation. Nucleic Acids Res 18:2069-2077
25. Chakraborty A, Zink M, Hodgson C (1995) Expression of VL30 vectors in human cells which are targets for gene therapy. Biochem Biophys Res Commun 209:677-683
26. French N, Norton J (1995) Construction of a retroviral vector incorporating mouse VL30 retrotransposon-derived transcriptional regulatory sequences. Anal Biochem 228:354-355
27. Norton J, Hogan B (1988) Temporal and tissue-specific expression of distinct retrovirus-like (VL30) elements during mouse development. Dev Biol 125:226-228
28. Heim R, Cubitt A, Tsien R (1995) Improved green fluorescence. Nature 373:663-664
29. Yu S, von Ruden T, Kantoff P (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 83:3194-3198
30. Miller A, Rosman G (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990
31. Junker U, Bohnlein E, Veres G (1995) Genetic instability of a MoMLV-hased antisense double-copy retroviral vector designed for HIV-1 gene therapy. Gene Ther 2:639-646
32. Hodgson C, Zink M, Chakraborty A, Solaiman F Xu G (1996) Synthetic retrovectors and gene targeting In: Felgner P et al (eds) Gene therapy and artificial self-assembling systems for gene transfer. ACS, Washington, pp 2-14
33. Devine S, Boeke J (1996) Integration of the yeast retrotransposon Ty1 is targeted to regions upstream of genes transcribed by RNA polymerase III. Genes Dev 10:620-633
34. Zou S, Ke N, Kim J, Voytas D (1996) The saccharomyces retrotransposon Ty5 integrates preferentially into regions of silent chromatin at the telomeres and mating loci. Genes Dev 10:634-645
35. Kirchner J, Connolly C, Sandmeyer S (1995) Requirement of RNA polymerase III transcription factors for in vitro positiion-specific integration of a retroviruslike element. Science 267: 1488-1491
36. Bushman F (1994) Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc Natl Acad Sci USA 91:9233-9237
37. Zimmerly S, Guo H, Perlman P, Lambowitz A (1995) Group II intron mobility occurs by target DNA-primed reverse transcription. Cell 82:545-554
38. Lasic D (1996) Liposomes. Science Med (May/June):34-43
39. Papahadjapoulos D (1991) Improved pharmacokinetics and efficacy of sterically stabilized liposomes. Proc Natl Acad Sci USA 88:11460-11464
40. Felgner J, Kumar R, Sridhar N, Wheeler C, Tsai Y, Border R, Ramsey P, Martin M, Felgner P (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269:2550-2561
41. Wilson T, Papahadjopoulos D, Taber R (1977) Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc Natl Acad Sci USA 74:3471-3475
42. Faller D, Baltimore D (1984) Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J Virol 49:269-272
43. Kondorosi E, Duda E (1982) Infection of cells with Sindbis virus nucleocapsids entrapped into liposomes. Biochem Biophys Res Commun 107:367-373
44. Wilson T, Papahadjopoulos D, Taber R (1977) Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc Natl Acad Sci USA 74:3471-3475
45. Lasic D, Papahadjopoulos D (1995) Liposomes revisited. Science 267:1275-1276
46. Konopka K, Davis B, Larsen, C, Alford D, Debs R, Duzgunes J (1990) Liposomes modulate human immunodeficiency virus infectivity. J Gen Virol 71:2899-2907
47. Hodgson C, Solaiman F (1996) Virosomes: cationic liposomes enhance retroviral transduction. Nat Biotechnol 14:339-342
48. Haensler J, Szoka F (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem 4:372-377
49. Szoka F, Haensler J (1995) Self-assembling polynucleotide delivery system comprising dendrimer polycation. World Intellectual Properly Organization (WIPO) patent WO95/02397
50. Remy J, Kichler A, Mordvinov V, Schuber F, Behr J (1995) Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage towards artificial viruses. Proc Natl Acad Sci USA 92: 1744-1748